GT BIOPHARMA INC

CUSIP: 36254L209 Class: COMMON

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 1,087,993 Value ($000) $277 Avg Close — Range —
Q3 2023
Shares 1,087,234 Value ($000) $262 Avg Close — Range —
Q2 2023
Shares 1,099,354 Value ($000) $343 Avg Close — Range —
Q1 2023
Shares 1,127,405 Value ($000) $620 Avg Close — Range —
Q4 2022
Shares 1,127,405 Value ($000) $999 Avg Close — Range —
Q3 2022
Shares 1,126,941 Value ($000) $1,983 Avg Close — Range —
Q2 2022
Shares 1,126,841 Value ($000) $3,369 Avg Close — Range —
Q1 2022
Shares 987,942 Value ($000) $2,845 Avg Close — Range —
Q4 2021
Shares 1,206,352 Value ($000) $3,680 Avg Close — Range —
Q3 2021
Shares 963,323 Value ($000) $6,493 Avg Close — Range —
Q2 2021
Shares 982,269 Value ($000) $15,225 Avg Close — Range —
Q1 2021
Shares 267,664 Value ($000) $1,831 Avg Close — Range —